Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 6/20 | 0.61 |
| ▸ | MME | P08473 | 2/20 | 0.59 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | CPA1 | P15085 | 1/20 | 0.58 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10076052 | 1.00 | ACE (0.61) | ACEMMEPSMB5L3MBTL1CPA1 | |
| SCHEMBL4182347 | 1.00 | ACE (0.61) | ACEMMEPSMB5L3MBTL1CPA1 | |
| SCHEMBL15692319 | 0.94 | PSMB5 (0.64) | ACEMMEPSMB5CPA1ACE2 | |
| SCHEMBL7901632 | 0.92 | MME (0.66) | ACEMMECPA1ACE2 | |
| SCHEMBL7903892 | 0.92 | MME (0.66) | ACEMMECPA1ACE2 | |
| SCHEMBL17361045 | 0.89 | ACE (0.65) | ACEMMEPSMB5L3MBTL1CPA1 | |
| SCHEMBL27724295 | 0.89 | ACE (0.65) | ACEMMEPSMB5L3MBTL1CPA1 | |
| SCHEMBL29337392 | 0.89 | ACE (0.54) | ACEMMEPSMB5L3MBTL1CPA1 | |
| SCHEMBL8533429 | 0.88 | PSMB5 (0.58) | ACEPSMB5 | |
| SCHEMBL16473192 | 0.88 | ALDH1A1 (0.60) | ACEPSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090186853-A1 | COMPOSITIONS COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | YU RUEY J | 2009-07-23 | — | — | US | claimed |
| EP-1865953-A4 | COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | YU RUEY J (US) | 2008-04-30 | — | — | EP | claimed |
| EP-1865953-A2 | COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | Yu, Ruey J., Dr. (US) | 2007-12-19 | — | — | EP | claimed |
| WO-2006101940-A2 | COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | YU, RUEY, J. (US) | 2006-09-28 | — | — | WO | claimed |
| US-20060211754-A1 | Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof | YU RUEY J | 2006-09-21 | — | — | US | claimed |
| US-20050171194-A1 | Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions | YU RUEY J (US) | 2005-08-04 | — | — | US | claimed |
| WO-2005055947-A2 | ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS | YU RUEY J (US) | 2005-06-23 | — | — | WO | claimed |
| CN-116926140-A | A fatty acylated amino acid with effect of enhancing or improving food taste, and its preparation method | 华南理工大学 | 2023-10-24 | — | — | CN | disclosed |
| CN-116546988-A | Prodrugs of 5α -hydroxy-6β - [2- (1H-imidazol-4-yl) ethylamino ] cholestan-3β -ol and pharmaceutical compositions for cancer treatment containing the same | 登德罗杰尼克斯公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-108395474-B | Method for coupling pyrazole with phenylalanine compound through visible light induction | 武汉大学 | 2021-02-19 | — | — | CN | disclosed |
| US-10620143-B2 | Sensor and method of detecting an analyte using 19F NMR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-04-14 | — | — | US | disclosed |
| US-20170143835-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | ADOCIA (FR) | 2017-05-25 | — | — | US | disclosed |
| US-9567297-B2 | Method for synthesizing of thioesters by using compound as catalyst | NATIONAL CENTRAL UNIVERSITY (TW) | 2017-02-14 | — | — | US | disclosed |
| EP-0080283-B1 | N-CARBOXYALKYLPROLINE-CONTAINING TRIPEPTIDES | SMITHKLINE BECKMAN CORPORATION (US) | 1986-01-29 | — | — | EP | disclosed |
| US-4380646-A | Method for the N-acylation of aminocarboxylic acids | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1983-04-19 | — | — | US | disclosed |
| EP-0033392-B1 | PROCESS FOR THE ACYLATION OF AMINO ACIDS | HÜLS TROISDORF AKTIENGESELLSCHAFT (DE) | 1983-03-30 | — | — | EP | disclosed |
| EP-0033392-A1 | Process for the acylation of amino acids | HÜLS TROISDORF AKTIENGESELLSCHAFT (DE) | 1981-08-12 | — | — | EP | disclosed |
| US-4262092-A | Process for producing N-acyl-D-phenylalanine ester | ETHYL CORPORATION (US) | 1981-04-14 | — | — | US | disclosed |
| US-4151198-A | Resolution of N-acyl-DL (+)-phenylalanines | AMERICAN CYANAMID COMPANY (US) | 1979-04-24 | — | — | US | disclosed |
| US-3996288-A | Method of producing aldehydes by hydroformylation | AJINOMOTO CO., INC. (JA) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170143835-A1 | SUBSTITUTED ANIONIC COMPOUNDS CONSISTING OF A BACKBONE MADE UP OF A DISCRETE NUMBER OF SACCHARIDE UNITS | ALG8, FUT8, UGT8 | ACE 540/4885MME 896/4885PSMB5 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.